Common questions about Fibrovein 3% (FAQ)
Q: Is the procedure with Fibrovein 3% considered painful?
A: Official product information, such as the Summary of Product Characteristics (SmPC), lists Local pain or burning at the injection site as a Common side effect. The sensation described, such as burning or pain at the site of administration, is commonly reported according to regulatory documents.
Q: What activities should I avoid right after a Fibrovein 3% procedure?
A: Regulatory documents state that post-treatment compression may affect a patient's ability to drive. Furthermore, regulatory documents indicate that the medicine is contraindicated in patients who are bedridden or unable to walk, underscoring the importance of post-procedure mobility.
Q: Can Fibrovein 3% be used to treat spider veins, or only larger varicose veins?
A: The 3% concentration is generally used for larger varicosities. However, the active ingredient, Sodium Tetradecyl Sulfate, is used as a sclerosing agent for both large varicose veins and smaller spider veins (telangiectasias). Lower concentrations of the active ingredient are typically used for smaller vessels.
Q: What happens if some of the Fibrovein 3% accidentally enters a deep vein?
A: Regulatory warnings stress the importance of correct administration technique to avoid injection into a deep vein. Deep vein thrombosis (DVT)—a blood clot in a deep vein—and pulmonary embolism (PE) are listed as very rare serious adverse events. Regulatory guidance requires administration by a healthcare professional with established expertise in venous anatomy and sclerotherapy technique.
Q: Is swelling of the ankle or foot normal after a Fibrovein 3% sclerotherapy session?
A: Localized swelling and tenderness around the injection site are common. Official documents also list Superficial thrombophlebitis as a common reaction. This condition may involve localized tenderness, hardening, or temporary swelling near the treated area.
Q: Is it normal to hear of discoloration or hyperpigmentation after Fibrovein 3% treatment?
A: Yes, regulatory documents classify Skin hyperpigmentation (skin discoloration) as a Common side effect following treatment with Fibrovein. This discoloration may be temporary, though official information also acknowledges the potential for long-term persistence.
Q: Do patients report numbness near the injection site after using Fibrovein 3%?
A: Official reports of undesirable effects list neurological symptoms such as Paraesthesia and anaesthesia (tingling, pricking sensation, or numbness) that may occur in the area near the injection site.
Q: What is the maximum number of veins that can be treated with Fibrovein 3% in one session?
A: The number of veins treated is limited by the total volume of the solution used. Official dosing information limits the total volume of the 3% liquid solution to a maximum of 4 mL per treatment session, which is typically divided into smaller injections across a maximum of four sites.
Q: Are there any long-term side effects reported from using Fibrovein 3%?
A: Regulatory reports document that long-term effects may include permanent skin discoloration along the injected vein. Regulatory reviews have noted limitations in the evidence available regarding long-term findings beyond two years of use.
Q: Is Fibrovein 3% effective for all sizes of varicose veins?
A: According to the product label, the 3% concentration is used for larger varicosities. The required strength of the sclerosing solution is dependent on the size and degree of the varicosity that needs to be closed off.
Q: How does the body get rid of the vein that is closed off by Fibrovein 3%?
A: The active ingredient causes the inner lining of the vein to damage and collapse, which then triggers the formation of a fibrous cord (a thrombus). This occluded vessel is eventually reabsorbed into the surrounding bodily tissue.
Q: Does taking certain vitamins or supplements affect the outcome of Fibrovein 3% sclerotherapy?
A: The official interaction profile provided in regulatory documents states that no specific interactions are currently known with common non-prescription medicinal products, vitamins, or herbal supplements.
Q: Are there different brand names for the same active ingredient as Fibrovein 3%?
A: Yes, the active chemical ingredient in Fibrovein, which is Sodium Tetradecyl Sulfate, is marketed under several other brand names in different regions around the world, such as Sotradecol or Trombovar.
Q: Do you feel the vein hardening after the Fibrovein 3% injection?
A: Yes, a hardening of the treated vein is a common finding. This hardening is consistent with the drug's mechanism of action, which causes the vein to close and become a firm, fibrous cord.
Q: Is there a specific mechanism of action that makes 3% appropriate for larger veins?
A: Official product information indicates that the strength of the solution required depends on the size and degree of the varicosity. The 3% concentration is used to ensure the necessary chemical intensity is reached to effectively occlude (close off) larger vein diameters.
